Medication producers could cut one third of their products in 2010
“In case of companies with significant sales – 45 companies with annual sales exceeding €5 million – the optimization of the portfolio will affect 10-20 percent of products. For the remaining drugs, produced by over 230 companies, optimization could reach up to 50 percent of the products. On the whole, we estimate that 1,500 of ...